PRIMARY PREVENTION IN PATIENTS WITH CORONARY HEART-DISEASE - THE APSIS STUDY

Authors
REHNQVIST N HJEMDAHL P BJORKANDER I ERIKSSON SV FORSLUND L HELD C WALLEN H BILLING E
Citation
N. Rehnqvist et al., PRIMARY PREVENTION IN PATIENTS WITH CORONARY HEART-DISEASE - THE APSIS STUDY, Cardiovascular drugs and therapy, 9, 1995, pp. 493-493
Citations number
NO
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
Journal title
Cardiovascular drugs and therapy → ACNP
ISSN journal
09203206
Volume
9
Year of publication
1995
Supplement
3
Pages
493 - 493
Database
ISI
SICI code
0920-3206(1995)9:<493:PPIPWC>2.0.ZU;2-D
Abstract
Symptomatic treatment of patients with angina pectoris is well establi shed and consists of nitrates, calcium antagonists, or beta blockers. All these drugs improve symptomatology and reduce signs of ischemia on exercise test or long-term electrocardiogram recordings. It is not kn own, however, whether these drugs also improve prognosis. The only dru g shown to improve prognosis is aspirin. In order to study the prognos tic effect of calcium antagonists and betablockers, these two drugs we re compared in the APSIS study.